Drug · DIN 02572095
FREHEMGO
SINGLE USE PREFILLED PEN
Authorized, not yet reported as sold
Authorized for sale in Canada; the company has not yet told Health Canada that it is on the market.
Status Approved since October 2, 2026.
- Drug Identification Number (DIN)
- 02572095
- Company (DIN owner)
- Novo Nordisk Canada IncMississauga, Ontario, Canada
- Schedule
- Prescription; Schedule d
- Dosage form
- Solution
- Route
- Subcutaneous
- Therapeutic class (ATC)
- Other systemic hemostatics B02BX
- Class
- Human
- Record last updated
- October 6, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| DENECIMIG | 1.6 MG | 0.8 ML |
Notices of Compliance
Health Canada approvals that name this DIN.
- October 2, 2026: NOC 38420New Drug Submission (NDS)
Other DINs named FREHEMGO
- DIN 02572109 · Approved
- DIN 02572117 · Approved
- DIN 02572125 · Approved
- DIN 02572133 · Approved